Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03794908 · ClinicalTrials.gov registry record · NA
Light Treatment to Improve Symptom Management of Fibromyalgia Syndrome
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT03794908 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 60 participants.
The verdict
NCT03794908, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effect a morning light treatment has on improving physical function, pain intensity, and pain sensitivity in people with fibromyalgia syndrome (FMS).
Interventions
- DEVICE Light therapy A (Bright) via the Re-Timer®
- DEVICE Light therapy B (Dim) via the Re-Timer®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2019-01-31 |
| Est. Completion | 2021-07-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03794908
The ClinicalTrials.gov registry entry for NCT03794908 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Light therapy A (Bright) via the Re-Timer® is the first listed.
NCT03794908 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03794908 about?
NCT03794908 is a clinical study titled "Light Treatment to Improve Symptom Management of Fibromyalgia Syndrome". The purpose of this study is to determine the effect a morning light treatment has on improving physical function, pain intensity, and pain sensitivity in people with fibromyalgia syndrome (FMS).
What is the current status of trial NCT03794908?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2019-01-31. Estimated completion is 2021-07-15.
What interventions are being tested in trial NCT03794908?
The interventions under investigation include: Light therapy A (Bright) via the Re-Timer® (DEVICE), Light therapy B (Dim) via the Re-Timer® (DEVICE).
Who is sponsoring clinical trial NCT03794908?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.